{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T18:51:52Z","timestamp":1788634312848,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.joms.2013.11.014","type":"journal-article","created":{"date-parts":[[2013,11,22]],"date-time":"2013-11-22T10:31:52Z","timestamp":1385116312000},"page":"1023-1031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Salivary Duct Carcinoma of the Parotid Gland: Is Adjuvant HER-2\u2013Targeted Therapy Required?"],"prefix":"10.1016","volume":"72","author":[{"given":"Jong Sil","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oh Jin","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Je","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2013.11.014_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/archotol.1991.01870150075010","article-title":"Primary parotid malignancies: A clinical and pathologic review","volume":"117","author":"Kane","year":"1991","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.joms.2013.11.014_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0030-4220(94)90119-8","article-title":"Salivary duct carcinoma. Part I. A\u00a0clinicopathologic evaluation and DNA image analysis of 13 cases with review of the literature","volume":"78","author":"Barnes","year":"1994","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.joms.2013.11.014_bib3","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archotol.133.10.1031","article-title":"Amplification and overexpression of HER2\/neu gene and HER2\/neu protein in salivary duct carcinoma of the parotid gland","volume":"133","author":"Cornolti","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.joms.2013.11.014_bib4","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1158\/1078-0432.CCR-12-1842","article-title":"Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment","volume":"19","author":"Nardi","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.joms.2013.11.014_bib5","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s12032-011-9884-1","article-title":"Targeted therapy with trastuzumab for advanced salivary ductal carcinoma: Case report and literature review","volume":"29","author":"Kaidar-Person","year":"2012","journal-title":"Med Oncol"},{"key":"10.1016\/j.joms.2013.11.014_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00301495","article-title":"[Salivary duct carcinoma: A\u00a0group of salivary gland tumors analogous to mammary duct carcinoma]","volume":"192","author":"Kleinsasser","year":"1968","journal-title":"Arch Klin Exp Ohren Nasen Kehlkopfheilkd"},{"key":"10.1016\/j.joms.2013.11.014_bib7","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1365-2559.2008.03135.x","article-title":"Salivary duct carcinoma in situ of the parotid gland","volume":"53","author":"Simpson","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.joms.2013.11.014_bib8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.anorl.2010.12.008","article-title":"Salivary duct carcinoma of the parotid","volume":"128","author":"Pons","year":"2011","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"10.1016\/j.joms.2013.11.014_bib9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00000478-200402000-00017","article-title":"Intraductal carcinoma of the oral cavity: A case report and a reappraisal of the concept of pure ductal carcinoma in situ in salivary duct carcinoma","volume":"28","author":"Cheuk","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.joms.2013.11.014_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2559.2007.02719.x","article-title":"Advances in salivary gland pathology","volume":"51","author":"Cheuk","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.joms.2013.11.014_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00000478-200403000-00004","article-title":"Invasive micropapillary salivary duct carcinoma: A distinct histologic variant with biologic significance","volume":"28","author":"Nagao","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.joms.2013.11.014_bib12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1440-1827.2008.02231.x","article-title":"Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland","volume":"58","author":"Yamamoto","year":"2008","journal-title":"Pathol Int"},{"key":"10.1016\/j.joms.2013.11.014_bib13","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/1097-0142(19900515)65:10<2307::AID-CNCR2820651024>3.0.CO;2-1","article-title":"Salivary duct carcinoma (cribriform salivary carcinoma of excretory ducts): A clinicopathologic and immunohistochemical study of 12 cases","volume":"65","author":"Brandwein","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.joms.2013.11.014_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2559.1995.tb01440.x","article-title":"Salivary duct carcinoma","volume":"26","author":"Grenko","year":"1995","journal-title":"Histopathology"},{"key":"10.1016\/j.joms.2013.11.014_bib15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","article-title":"Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer","volume":"244","author":"Slamon","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.joms.2013.11.014_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1078\/0344-0338-00136","article-title":"Salivary duct carcinoma\u2014A highly aggressive salivary gland tumor with HER-2\/neu oncoprotein overexpression","volume":"197","author":"Skalova","year":"2001","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.joms.2013.11.014_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<129::AID-IJC6>3.0.CO;2-4","article-title":"c-erbB-2 (HER-2\/neu) protein and drug resistance in breast cancer patients treated with induction chemotherapy","volume":"84","author":"Vargas-Roig","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.joms.2013.11.014_bib18","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1200\/JCO.2010.32.8351","article-title":"Androgen receptor-positive salivary duct carcinoma: A disease entity with promising new treatment options","volume":"29","author":"Jaspers","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.joms.2013.11.014_bib19","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1093\/annonc\/mdt338","article-title":"Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumours","volume":"24","author":"Cros","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.joms.2013.11.014_bib20","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1158\/1078-0432.CCR-03-0253","article-title":"HER2 expression in salivary gland carcinomas: Dependence on histological subtype","volume":"10","author":"Glisson","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.joms.2013.11.014_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/erc.0.0080011","article-title":"The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification","volume":"8","author":"Prenzel","year":"2001","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.joms.2013.11.014_bib22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/stem.160413","article-title":"The HER-2\/neu oncogene in breast cancer: Prognostic factor, predictive factor, and target for therapy","volume":"16","author":"Ross","year":"1998","journal-title":"Stem Cells"},{"key":"10.1016\/j.joms.2013.11.014_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.critrevonc.2009.10.004","article-title":"Major and minor salivary gland tumors","volume":"74","author":"Guzzo","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.joms.2013.11.014_bib24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joms.2013.11.014_bib25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/COC.0b013e318191bfb0","article-title":"Trastuzumab-based therapy for patients with HER2-positive breast cancer: From early scientific development to foundation of care","volume":"33","author":"Brufsky","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.joms.2013.11.014_bib26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0140-6736(09)61964-4","volume":"375","author":"Gianni","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.joms.2013.11.014_bib27","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1002\/cncr.25120","article-title":"Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer","volume":"116","author":"Chang","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.joms.2013.11.014_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1245\/s10434-009-0766-0","article-title":"Targeting gastric cancer with trastuzumab: New clinical practice and innovative developments to overcome resistance","volume":"17","author":"Roukos","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.joms.2013.11.014_bib29","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/hed.20614","article-title":"Salivary duct carcinoma: A clinical and histologic review with implications for trastuzumab therapy","volume":"29","author":"Nabili","year":"2007","journal-title":"Head Neck"},{"key":"10.1016\/j.joms.2013.11.014_bib30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1017\/S0022215108002314","article-title":"Biological therapy of salivary duct carcinoma","volume":"123","author":"Nashed","year":"2009","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.joms.2013.11.014_bib31","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/hed.20714","article-title":"Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab-based therapy","volume":"30","author":"Prat","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.joms.2013.11.014_bib32","article-title":"Definitive treatment of androgen receptor-positive salivary duct carcinoma with androgen deprivation therapy and external beam radiotherapy","author":"Soper","year":"2013","journal-title":"Head Neck"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239113014250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239113014250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:43:48Z","timestamp":1759509828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239113014250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0278239113014250"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2013.11.014","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salivary Duct Carcinoma of the Parotid Gland: Is Adjuvant HER-2\u2013Targeted Therapy Required?","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2013.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}